These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3092618

  • 1. Disposition kinetics of encainide and metabolites.
    Roden DM, Wood AJ, Wilkinson GR, Woosley RL.
    Am J Cardiol; 1986 Aug 29; 58(5):4C-9C. PubMed ID: 3092618
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
    Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM.
    Circulation; 1988 Feb 29; 77(2):380-91. PubMed ID: 3123092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.
    Carey EL, Duff HJ, Roden DM, Primm RK, Wilkinson GR, Wang T, Oates JA, Woosley RL.
    J Clin Invest; 1984 Feb 29; 73(2):539-47. PubMed ID: 6421879
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide.
    Harrison DC, Kates RE, Quart BD.
    Am J Cardiol; 1986 Aug 29; 58(5):66C-73C. PubMed ID: 3092622
    [Abstract] [Full Text] [Related]

  • 10. Encainide disposition in patients with chronic cirrhosis.
    Bergstrand RH, Wang T, Roden DM, Avant GR, Sutton WW, Siddoway LA, Wolfenden H, Woosley RL, Wilkinson GR, Wood AJ.
    Clin Pharmacol Ther; 1986 Aug 29; 40(2):148-54. PubMed ID: 3089668
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of encainide in patients with cirrhosis.
    Wensing G, Mönig H, Ohnhaus EE, Hoensch HP.
    Cardiovasc Drugs Ther; 1991 Aug 29; 5(4):733-9. PubMed ID: 1909559
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide.
    Winkle RA, Peters F, Kates RE, Harrison DC.
    Am J Cardiol; 1983 Apr 29; 51(7):1182-8. PubMed ID: 6404150
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.